Ascelia Pharma AB's total assets for Q1 2026 were kr96.87M, a decrease of -13.47% from the previous quarter. SE:ACE total liabilities were kr13.95M for the fiscal quarter, a 11.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.